Find a Trial
Trial Summary
| Protocol No. | CTO-INCB-50465-304 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Sayar, Hamid | ||
| Scope | National | ||
| Phase | Phase III | ||
| Age Group | Adult | ||
| Title | A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kδ Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib. | ||
| Applicable Disease Sites | Leukemia, other | ||
| Participating Institutions | IU Health Central Indiana Cancer Centers | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||